Cargando…
Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645925/ https://www.ncbi.nlm.nih.gov/pubmed/33107132 http://dx.doi.org/10.1111/cpr.12944 |
| _version_ | 1783606715121401856 |
|---|---|
| author | Wu, Jun Zhou, Xing Tan, Yuanqing Wang, Liu Li, Tianda Li, Zhongwen Gao, Tingting Fan, Jiaqi Guo, Baojie Li, Wei Hao, Jie Wang, Xianguang Hu, Baoyang |
| author_facet | Wu, Jun Zhou, Xing Tan, Yuanqing Wang, Liu Li, Tianda Li, Zhongwen Gao, Tingting Fan, Jiaqi Guo, Baojie Li, Wei Hao, Jie Wang, Xianguang Hu, Baoyang |
| author_sort | Wu, Jun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7645925 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76459252020-11-06 Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs Wu, Jun Zhou, Xing Tan, Yuanqing Wang, Liu Li, Tianda Li, Zhongwen Gao, Tingting Fan, Jiaqi Guo, Baojie Li, Wei Hao, Jie Wang, Xianguang Hu, Baoyang Cell Prolif Letters to the Editor John Wiley and Sons Inc. 2020-10-26 /pmc/articles/PMC7645925/ /pubmed/33107132 http://dx.doi.org/10.1111/cpr.12944 Text en © 2020 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Wu, Jun Zhou, Xing Tan, Yuanqing Wang, Liu Li, Tianda Li, Zhongwen Gao, Tingting Fan, Jiaqi Guo, Baojie Li, Wei Hao, Jie Wang, Xianguang Hu, Baoyang Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs |
| title | Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs |
| title_full | Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs |
| title_fullStr | Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs |
| title_full_unstemmed | Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs |
| title_short | Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs |
| title_sort | phase 1 trial for treatment of covid‐19 patients with pulmonary fibrosis using hesc‐imrcs |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645925/ https://www.ncbi.nlm.nih.gov/pubmed/33107132 http://dx.doi.org/10.1111/cpr.12944 |
| work_keys_str_mv | AT wujun phase1trialfortreatmentofcovid19patientswithpulmonaryfibrosisusinghescimrcs AT zhouxing phase1trialfortreatmentofcovid19patientswithpulmonaryfibrosisusinghescimrcs AT tanyuanqing phase1trialfortreatmentofcovid19patientswithpulmonaryfibrosisusinghescimrcs AT wangliu phase1trialfortreatmentofcovid19patientswithpulmonaryfibrosisusinghescimrcs AT litianda phase1trialfortreatmentofcovid19patientswithpulmonaryfibrosisusinghescimrcs AT lizhongwen phase1trialfortreatmentofcovid19patientswithpulmonaryfibrosisusinghescimrcs AT gaotingting phase1trialfortreatmentofcovid19patientswithpulmonaryfibrosisusinghescimrcs AT fanjiaqi phase1trialfortreatmentofcovid19patientswithpulmonaryfibrosisusinghescimrcs AT guobaojie phase1trialfortreatmentofcovid19patientswithpulmonaryfibrosisusinghescimrcs AT liwei phase1trialfortreatmentofcovid19patientswithpulmonaryfibrosisusinghescimrcs AT haojie phase1trialfortreatmentofcovid19patientswithpulmonaryfibrosisusinghescimrcs AT wangxianguang phase1trialfortreatmentofcovid19patientswithpulmonaryfibrosisusinghescimrcs AT hubaoyang phase1trialfortreatmentofcovid19patientswithpulmonaryfibrosisusinghescimrcs |